Trial Profile
Phase I study of TS-1 with paclitaxel for gastric carcinomatosa.
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Paclitaxel (Primary)
- Indications Gastric cancer
- Focus Adverse reactions
- 20 Dec 2011 New trial record